Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 24376 AL 24390

LRP1 at the crossroads of Parkinson's and Alzheimer's: Divergent roles in α-synuclein and amyloid pathology

Alshahrani SM, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Shokr MM, Kadasah SF, Alexiou A, Papadakis M, El-Saber Batiha G.

Eur J Pharmacol. 2025 Sep 5;1002:177830. doi: 10.1016/j.ejphar.2025.177830. Epub 2025 Jun 6.

Effect of comprehensive geriatric assessment intervention on serum S100β levels and clinical outcomes in patients with Alzheimer's disease

Wang DW, Qin XT, Wang G, Liu J, Xu YP, Tian Y, Liu B.

J Alzheimers Dis. 2025 Jul;106(2):686-694. doi: 10.1177/13872877251344544. Epub 2025 Jul 1.

The Role of Inflammation in Neurodegenerative Diseases: Parkinson's Disease, Alzheimer's Disease, and Multiple Sclerosis

Fołta J, Rzepka Z, Wrześniok D.

Int J Mol Sci. 2025 May 28;26(11):5177. doi: 10.3390/ijms26115177.

Antimicrobial peptides and proteins in Alzheimer's and Parkinson's diseases: implications for biomarker exploration

Yong SJ, Teoh SL, Parhar IS, Soga T, Lim WL, Chew J.

Rev Neurosci. 2025 Jun 13;36(8):849-879. doi: 10.1515/revneuro-2025-0034. Print 2025 Dec 17.

A hypothesis explaining Alzheimer's disease, Parkinson's disease, and dementia with Lewy bodies overlap

Lau VZ, Awogbindin IO, Frenkel D, Whitehead SN, Tremblay MÈ.

Alzheimers Dement. 2025 Jun;21(6):e70363. doi: 10.1002/alz.70363.

The cognitive and neurological implications of toxoplasma gondii infection: Evidence from a systematic review and meta-analysis

Kavakebian M, Ghandali T, Nasiri H, Ramezani-Moghadam F, Alizadeh S, Alizadeh S, Silakhor M, Rajabi M, Mirmazhari A, Asgarian P, Rahimi H, Karimi M, Moosazadeh M.

Acta Trop. 2025 Aug;268:107705. doi: 10.1016/j.actatropica.2025.107705. Epub 2025 Jun 21.

Advancing Amyloid Aggregation Research: A Focus on Innovative Therapies, Molecular Modeling and Nano-Delivery Systems in Alzheimer's Disease

Hasan U, Jain H, Ali R.

Curr Drug Targets. 2025;26(11):779-798. doi: 10.2174/0113894501388678250618070927.

Targeting the redox neuroinflammatory nexus: insights into Alzheimer's and Parkinson's diseases

Dharshini LCP, Sakthivel KM, Rex KGR, Rasmi RR.

Inflammopharmacology. 2025 Jul;33(7):3885-3895. doi: 10.1007/s10787-025-01831-w. Epub 2025 Jul 2.

Detoxification and age-related neurodegenerative diseases: Correlation and therapeutic potential

Yan Y, Maisenbacher M, Huang C, Fan S.

Pharmacol Res. 2025 Aug;218:107849. doi: 10.1016/j.phrs.2025.107849. Epub 2025 Jul 2.

Neuroprotective effects of essential oils in animal models of Alzheimer's and Parkinson's disease: a systematic review

Macedo ADES, Ferreira TM, Krejcová LV, Rocha FAF, da Silva JKR, Pedrosa LRR, Gomes BD.

PeerJ. 2025 Jul 10;13:e19643. doi: 10.7717/peerj.19643. eCollection 2025.

Efficacy of repetitive transcranial magnetic stimulation in cognitive impairment of neurodegenerative diseases: a systematic review and meta-analysis

Zhang Y, Xu K, Wang Y, Shen Y, Liu Z, Zhang C, Zhou Y, Lv P, Bai Y, Wang S.

BMC Neurol. 2025 Jul 17;25(1):295. doi: 10.1186/s12883-025-04292-4.

Digital Therapeutics for Alzheimer's and Parkinson's Diseases: Current Trends and Future Perspectives

Jeong YJ, Lee HJ, Kim JS, Kim SJ, Jo U, Park JY, Jun SJ, Lee WS, Song M, Kim D, Cho G, Song JH, Hoe HS.

Med Res Rev. 2026 Jan;46(1):316-327. doi: 10.1002/med.70005. Epub 2025 Jul 31.

Next-generation CRISPR gene editing tools in the precision treatment of Alzheimer's and Parkinson's disease

Meshram HK, Gupta SK, Gupta A, Nagori K, Ajazuddin.

Ageing Res Rev. 2025 Sep;111:102851. doi: 10.1016/j.arr.2025.102851. Epub 2025 Aug 5.

Searching Heterocyclic Scaffolds Used to Treat Alzheimer's Disease: A Review

Kale MA, Faisal M.

Curr Drug Res Rev. 2025;17(2):266-281. doi: 10.2174/0125899775290026240612104933.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias